CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionCrossmark Global Holdings, Inc.
Latest Disclosed Ownership20,869 shares
Latest Disclosed Value $ 6,163,671
Crossmark Global Holdings, Inc. reports 6.06% increase in ownership of MX4A / CME Group Inc.

On May 11, 2026 - Crossmark Global Holdings, Inc. filed a 13F-HR form disclosing ownership of 20,869 shares of CME Group Inc. (DE:MX4A) valued at $5,330,986 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 19,677 shares of CME Group Inc.. This represents a change in shares of 6.06% during the quarter. The current value of the position is $4,545,268 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F CME GROUP COM 12572Q105 20,869 1,192 6.06 6,164 14.70 0.0900
2026-02-03 2025-12-31 13F CME GROUP COM 12572Q105 19,677 625 3.28 5,373 4.39 0.0766
2025-11-12 2025-09-30 13F CME GROUP COM 12572Q105 19,052 482 2.60 5,148 0.57 0.0771
2025-08-08 2025-06-30 13F CME GROUP COM 12572Q105 18,570 1,554 9.13 5,118 13.38 0.0826
2025-04-30 2025-03-31 13F CME GROUP COM 12572Q105 17,016 161 0.96 4,514 150,366.67 0.0796
2025-01-16 2024-12-31 13F CME GROUP COM 12572Q105 16,855 -1,570 -8.52 4 -25.00 0.0714
2024-11-04 2024-09-30 13F CME GROUP COM 12572Q105 18,425 -395 -2.10 4 33.33 0.0725
2024-07-29 2024-06-30 13F CME GROUP COM 12572Q105 18,820 -344 -1.80 4 -25.00 0.0707
2024-05-13 2024-03-31 13F CME GROUP COM 12572Q105 19,164 -854 -4.27 4 0.00 0.0791
2024-02-13 2023-12-31 13F CME GROUP COM 12572Q105 20,018 -262 -1.29 4 0.00 0.0875
2023-11-08 2023-09-30 13F CME GROUP COM 12572Q105 20,280 -502 -2.42 4 0.00 0.0993
2023-07-31 2023-06-30 13F CME GROUP COM 12572Q105 20,782 211 1.03 4 33.33 0.0892
2023-05-12 2023-03-31 13F CME GROUP COM 12572Q105 20,571 -693 -3.26 4 0.00 0.0927
2023-01-19 2022-12-31 13F CME GROUP COM 12572Q105 21,264 1,215 6.06 4 -99.92 0.0891
2022-11-01 2022-09-30 13F CME GROUP COM 12572Q105 20,049 -1,766 -8.10 3,551 -20.49 0.0985
2022-07-29 2022-06-30 13F CME GROUP COM 12572Q105 21,815 -4,853 -18.20 4,466 -29.59 0.1157
2022-05-11 2022-03-31 13F CME GROUP COM 12572Q105 26,668 6,486 32.14 6,343 37.56 0.1414
2022-01-10 2021-12-31 13F CME GROUP COM 12572Q105 20,182 -243 -1.19 4,611 16.73 0.1001
2021-10-21 2021-09-30 13F/A-1 CME GROUP COM 12572Q105 20,425 440 2.20 3,950 -7.06 0.0925
2021-10-13 2021-09-30 13F CME GROUP COM 12572Q105 8,040 -11,945 461 0.0528
2021-07-21 2021-06-30 13F CME GROUP COM 12572Q105 19,985 161 0.81 4,250 4.96 0.0999
2021-04-15 2021-03-31 13F CME GROUP COM 12572Q105 19,824 -665 -3.25 4,049 8.55 0.1003
2021-01-14 2020-12-31 13F CME GROUP COM 12572Q105 20,489 -144 -0.70 3,730 8.05 0.0943
2020-10-08 2020-09-30 13F CME GROUP COM 12572Q105 20,633 -287 -1.37 3,452 1.53 0.0968
2020-08-14 2020-06-30 13F CME GROUP COM 12572Q105 20,920 467 2.28 3,400 -3.87 0.0992
2020-04-28 2020-03-31 13F CME GROUP COM 12572Q105 20,453 -74 -0.36 3,537 -14.15 0.1266
2020-02-06 2019-12-31 13F CME GROUP COM 12572Q105 20,527 -401 -1.92 4,120 -6.85 0.1132
2019-10-09 2019-09-30 13F CME GROUP COM 12572Q105 20,928 -1,540 -6.85 4,423 1.42 0.1291
2019-07-09 2019-06-30 13F CME GROUP COM 12572Q105 22,468 330 1.49 4,361 19.71 0.1223
2019-05-02 2019-03-31 13F CME GROUP COM 12572Q105 22,138 -125 -0.56 3,643 -13.01 0.1034
2019-01-31 2018-12-31 13F CME GROUP COM 12572Q105 22,263 -1,900 -7.86 4,188 1.82 0.1298
2018-11-08 2018-09-30 13F/A-1 CME GROUP COM 12572Q105 24,163 -1,637 -6.34 4,113 -2.74 0.1044
2018-11-06 2018-09-30 13F CME GROUP COM 12572Q105 25,800 0 4,229
2018-07-31 2018-06-30 13F CME GROUP COM 12572Q105 25,800 -974 -3.64 4,229 -2.33 0.1134
2018-04-16 2018-03-31 13F CME GROUP COM 12572Q105 26,774 -2,267 -7.81 4,330 2.10 0.1119
2018-02-05 2017-12-31 13F CME GROUP COM 12572Q105 29,041 750 2.65 4,241 10.47 0.1019
2017-10-27 2017-09-30 13F CME GROUP COM 12572Q105 28,291 0 0.00 3,839 0.00 0.0990
2017-10-25 2016-09-30 13F CME GROUP COM 12572Q105 28,291 28,291 3,839 0.0990
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.